Today: 11 June 2026
Browse Category

NASDAQ:AXLA 16 January 2026 - 20 May 2026

Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

Astera Labs shares rose 13.3% to $244.26 on Tuesday after management outlined a faster ramp for its Scorpio X fabric switches and optical networking tied to Nvidia’s NVLink Fusion. The move followed presentations at J.P. Morgan’s tech conference and comes ahead of Nvidia’s earnings Wednesday. Astera’s first-quarter revenue jumped 93% to $308.4 million, with second-quarter guidance above analyst forecasts.
20 May 2026
·
Astera Labs Stock Rises After AI Earnings Beat, But a Bigger Test Comes Next

Astera Labs Stock Rises After AI Earnings Beat, But a Bigger Test Comes Next

Astera Labs posted first-quarter revenue of $308.4 million, up 93% year-over-year, and adjusted earnings of 61 cents a share, both above analyst estimates. Shares rose 1.27% after hours. The company forecast second-quarter revenue of $355 million to $365 million, also ahead of expectations. CEO Jitendra Mohan cited strong demand for PCIe 6 products and initial shipments of the Scorpio X-Series AI switch.
5 May 2026
··
Astera Labs stock jumps on RBC call as traders size up the next catalyst

Astera Labs stock jumps on RBC call as traders size up the next catalyst

Astera Labs shares rose 4.8% to $182.80 after RBC Capital Markets initiated coverage with an Outperform rating and a $225 target. RBC cited strong retimer demand and upcoming Scorpio switch launches as catalysts. The move comes ahead of Astera’s Feb. 10 earnings report and amid heightened scrutiny of AI chip stocks. Trading volume reached about 4.2 million shares Friday.
16 January 2026
··

Stock Market Today

  • Redwire Stock Rises on $500 Million At-The-Market Share Sale Plan
    June 11, 2026, 10:42 AM EDT. Redwire (RDW) shares climbed Thursday following the announcement of a $500 million at-the-market (ATM) equity program, allowing the company to gradually sell new shares at market prices. The move aims to boost cash for working capital, debt refinancing, acquisitions, and R&D, but introduces dilution risk as existing shareholders' stakes may decrease. Shares opened at $14.88, peaked at $16.26, and last traded at $16.11, up $1.24 from the prior close, with nearly 9.7 million shares changing hands. The new shares could increase the total outstanding from 238.8 million to around 265.8 million, depending on sale prices. Market reaction reflects investor uncertainty about dilution balanced against Redwire's growth funding needs.

Latest articles

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Redwire Stock Bounces as $500 Million Share Sale Draws Focus

Redwire Stock Bounces as $500 Million Share Sale Draws Focus

11 June 2026
Redwire stock jumped $1.24 to $16.11 Thursday after unveiling a $500 million at-the-market share sale, raising investor concerns about dilution versus growth funding; the new program could increase shares outstanding by about 11%, with the company’s 2026 revenue forecast and backlog now under scrutiny to justify the added supply.
Coupang Rises as $410 Million Korea Data Fine Finally Lands

Coupang Rises as $410 Million Korea Data Fine Finally Lands

11 June 2026
Coupang shares jumped 5.6% after South Korea imposed a record $410 million privacy fine for a 2025 data breach, as investors welcomed clarity on regulatory risk despite the penalty hitting Q2 operating expenses; the company plans to appeal, but ongoing customer trust and margin pressures remain key risks.
Go toTop